TNF Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: TNF Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q3 2024.
TNF Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.83M, a 52.5% increase year-over-year.
TNF Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$12.9M, a 19.6% increase year-over-year.
TNF Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$17.1M, a 12% decline from 2022.
TNF Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$15.3M, a 47% increase from 2021.
TNF Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$28.8M, a 204% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$12.9M	-$1.83M	+$2.02M	+52.5%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	-$14.9M	-$3.37M	+$2.41M	+41.7%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-19
Q1 2024	-$17.3M	-$2.78M	-$194K	-7.5%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	-$17.1M	-$4.91M	-$1.1M	-28.9%	Oct 1, 2023	Dec 31, 2023	10-K	2024-04-01
Q3 2023	-$16M	-$3.84M	-$133K	-3.58%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-14
Q2 2023	-$15.9M	-$5.78M	-$2.14M	-58.7%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-19
Q1 2023	-$13.8M	-$2.59M	+$1.53M	+37.2%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-15
Q4 2022	-$15.3M	-$3.81M	-$774K	-25.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-04-01
Q3 2022	-$14.5M	-$3.71M	+$698K	+15.8%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-14
Q2 2022	-$15.2M	-$3.64M	+$14.6M	+80.1%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	-$29.8M	-$4.12M	-$1.03M	-33.4%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	-$28.8M	-$3.03M	-$1.43M	-88.8%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-31
Q3 2021	-$27.4M	-$4.41M	-$1.17M	-36%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	-$26.2M	-$18.3M	-$17.2M	-1569%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-15
Q1 2021	-$9.03M	-$3.09M	+$455K	+12.8%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-16
Q4 2020	-$9.49M	-$1.61M	-$746K	-86.6%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-31
Q3 2020	-$8.74M	-$3.24M	-$2.39M	-282%	Jul 1, 2020	Sep 30, 2020	10-Q/A	2021-11-15
Q2 2020	-$6.35M	-$1.09M	-$273K	-33.2%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-16
Q1 2020	-$6.08M	-$3.54M	-$2.6M	-277%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-18
Q4 2019	-$3.47M	-$861K	+$2.07M	+70.6%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-01
Q3 2019	-$5.54M	-$849K	+$2.27M	+72.8%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-16
Q2 2019	-$7.82M	-$822K	+$1.29M	+61.1%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-14
Q1 2019	-$9.11M	-$940K	+$953K	+50.4%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-15
Q4 2018	-$10.1M	-$2.93M	+$324K	+9.96%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-25
Q3 2018	-$10.4M	-$3.12M	-$1.95M	-165%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-14
Q2 2018	-$8.44M	-$2.11M	-$1.29M	-157%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-14
Q1 2018	-$7.15M	-$1.89M	-$531K	-39%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-20
Q4 2017	-$6.61M	-$3.25M	-$2.16M	-196%	Oct 1, 2017	Dec 31, 2017	10-K	2019-04-01
Q3 2017	-$4.46M	-$1.18M	-$1.48M	-491%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-14
Q2 2017	-$2.98M	-$821K	+$194K	+19.1%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-14
Q1 2017	-$3.17M	-$1.36M	+$155K	+10.2%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-07-13
Q4 2016	-$3.33M	-$1.1M	+$2.76M	+71.5%	Oct 1, 2016	Dec 31, 2016	10-K/A	2018-07-13
Q3 2016	-$6.09M	$301K	+$2.65M		Jul 1, 2016	Sep 30, 2016	10-Q/A	2018-07-13
Q2 2016	-$8.74M	-$1.01M	+$1.1M	+52.1%	Apr 1, 2016	Jun 30, 2016	10-Q/A	2018-07-13
Q1 2016	-$9.84M	-$1.52M	-$157K	-11.5%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-15
Q4 2015	-$9.68M	-$3.86M	-$2.93M	-314%	Oct 1, 2015	Dec 31, 2015	10-K	2017-04-11
Q3 2015	-$6.76M	-$2.35M	-$1.2M	-105%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-14
Q2 2015	-$5.55M	-$2.12M	-$1.6M	-311%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-11
Q1 2015	-$3.95M	-$1.36M	-$747K	-122%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-12
Q4 2014	-$3.2M	-$932K	-$152K	-19.4%	Oct 1, 2014	Dec 31, 2014	10-K	2016-03-30
Q3 2014	-$3.05M	-$1.14M	-$598K	-110%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-13
Q2 2014	-$2.45M	-$516K	-$62.7K	-13.8%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-18
Q1 2014	-$2.39M	-$613K	-$581K	-1824%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-14
Q4 2013	-$1.81M	-$781K			Oct 1, 2013	Dec 31, 2013	10-K	2015-03-23
Q3 2013		-$545K			Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-13
Q2 2013		-$453K			Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-12
Q1 2013		-$31.9K			Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.